💎 Total Health Panel — Complete

What this panel can settle, and by what logic

At 130 markers the useful question is not what the panel can find. It is what the extra $400 over the tier below actually buys, and the answer is depth in three specific places rather than more of everything.

1. The measurements you make once and never repeat. Lipoprotein(a) — Lp(a) is essentially genetic and APOE Genotyping does not change, so recording them in a definitive baseline means never ordering them again — and an Lp(a) above 50 mg/dL is a lifelong reason to hold ApoB (Apolipoprotein B) lower than the population target Johannesen 2021.
2. The nutrient block read together instead of one marker at a time. Ferritin beside hs-CRP (High-Sensitivity C-Reactive Protein) is a different statement from ferritin alone, because ferritin is an acute-phase protein and the BRINDA method exists to adjust micronutrient biomarkers for exactly that Luo 2023. A ferritin of 70 ng/mL with a CRP of 6 mg/L is not the same fact as 70 ng/mL with a CRP of 0.5 mg/L, and only a panel carrying both can make the correction.
3. The hormone block run on the right assays. At male concentrations estradiol has to come off a sensitive method or the number should not be carried Rosner 2013, and steroid reference intervals are age- and sex-specific in ways a single adult interval hides Kunz 2023.

What it cannot settle, and what would

It cannot tell you which of its flags matters, and at 130 markers there will be flags. A reference interval is drawn to contain the central 95% of a healthy population, so about 1 result in 20 from a well person falls outside one by construction — on 130 markers that is roughly 6 expected out-of-range values before anything is wrong with you. Which ones get flagged also depends on whose interval your laboratory used: variation between assays and between reference intervals changes the diagnosis itself in endocrine testing Lorde 2023.

It cannot stop a wider panel from manufacturing disease. Widening a definition creates cases without anybody becoming ill: lowering the abnormal total cholesterol threshold from 240 to 200 mg/dL created 42 million newly treatment-eligible people in the United States, and redefining hypertension produced 14% to 33% overdiagnosis depending on the criteria used Bandovas 2022. A panel graded against optimal rather than reference ranges is running that same arithmetic on you privately.

It still cannot see a structure. No number in 130 images a liver, a coronary artery or a vertebra, and a normal ALT does not exclude fatty liver in the first place Lonardo 2024.

And it does not tell you twice as much as the tier below. $895 against $495 is roughly 30% more markers, and the four that predict outcomes — ApoB (Apolipoprotein B), HbA1c (Hemoglobin A1c), Fasting Insulin and hs-CRP (High-Sensitivity C-Reactive Protein) — are on both Johannesen 2021. Buy this one to fix a baseline you intend to track for a decade. Buy the cheaper one to answer a question this year.

Draw conditions that decide whether the money is wasted

The draw matters more here than on any other pre-built, for a reason specific to a baseline: the point of 130 markers is comparison across years, so a badly drawn one spoils every future comparison rather than one morning.

1. Fast 9 to 12 hours, draw 7 to 10am, and write down the laboratory. Assays and their reference intervals differ enough between platforms to change an endocrine result from normal to abnormal Lorde 2023, so the same panel repeated elsewhere in 3 years is not the same measurement.
2. No biotin for 3 days. The wider the panel, the more of it is streptavidin-based, and preanalytical interference is the largest single source of wrong immunoassay results Caruso 2020; supplement doses of 5,000 to 10,000 mcg sit far above the threshold at which biotin displaces the assay Li 2020.
3. Not within 2 weeks of an illness. An acute-phase response does not move one marker on a panel this size. It moves ferritin, hs-CRP, albumin, zinc and the white cell differential at once Luo 2023, which is 5 flags with one cause.
4. No hard training for 48 hours, which otherwise lifts creatine kinase, AST, ALT and creatinine together and adds 4 more.

How you would know it answered your question, and what each pattern means next

A baseline has no abnormal column. It has a short list of results that change what you do, and a long list you record and leave alone.

• Lipoprotein(a) — Lp(a) above 50 mg/dL: record it, never order it again, and treat it as a permanent reason to be stricter about ApoB (Apolipoprotein B) Johannesen 2021.
• A single marginal flag with a normal partner marker: leave it. A raised bilirubin with normal liver enzymes is usually Gilbert syndrome, and the arithmetic above says isolated flags are expected Lorde 2023. Check it on the next panel, not next week.
• Two related markers moving together — ALT with HbA1c (Hemoglobin A1c), Ferritin with transferrin saturation on the Iron Panel (Iron, TIBC, Transferrin Saturation), hs-CRP (High-Sensitivity C-Reactive Protein) with ApoB (Apolipoprotein B) — is the pattern worth following. Retest that pair at 12 weeks, the shortest interval at which HbA1c and ALT are reporting new information rather than the same red cells and the same liver fat Lonardo 2024.
• Everything acceptable: the next panel is 12 months away and does not have to be this one. Repeating $895 annually buys a great deal of data whose main effect is more flags to explain Bandovas 2022.

Sources read for these sections

• Lorde N, et al. Impact of Variation between Assays and Reference Intervals in the Diagnosis of Endocrine Disorders. Diagnostics (Basel) 2023 · PMID 37998589
• Bandovas JP, et al. Broadening risk factor or disease definition as a driver for overdiagnosis: A narrative review. Journal of Internal Medicine 2022 · PMID 35253285
• Johannesen CDL, et al. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. Journal of the American College of Cardiology 2021 · PMID 33736827
• Luo H, et al. A Practical Guide to Adjust Micronutrient Biomarkers for Inflammation Using the BRINDA Method. Journal of Nutrition 2023 · PMID 36792034
• Rosner W, et al. Challenges to the measurement of estradiol: an endocrine society position statement. Journal of Clinical Endocrinology and Metabolism 2013 · PMID 23463657
• Kunz S, et al. Age- and sex-adjusted reference intervals for steroid hormones measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) using a widely available kit. Endocrine Connections 2023 · PMID 37938144
• Lonardo A. Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!. World Journal of Gastroenterology 2024 · PMID 38983954
• Caruso B, et al. Causes of Preanalytical Interferences on Laboratory Immunoassays - A Critical Review. EJIFCC 2020 · PMID 32256291
• Li D, Ferguson A, Cervinski MA, Lynch KL, Kyle PB. AACC Guidance Document on Biotin Interference in Laboratory Tests. J Appl Lab Med 2020 · PMID 32445355